Twenty-two participants with no sleep complaints underwent @ conditions in a counterbalanced crossover study : ( @ ) zolpidem-ER @ mg ( bedtime dosing ) , ( @ ) zaleplon @ mg ( middle-of-the-night dosing ) , and ( @ ) placebo .